Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Long-Term Investments (2010 - 2025)

Analysis

Cerenome (CNSY) Long-Term Investments (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn -4.00 Mn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.41 Bn 44.41 Bn - -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 372.10 Mn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -
10 Cerenome 20.42 Mn 11.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 4.60 Mn
Dec 31, 2024 3.50 Mn
Mar 31, 2013 37,000.00
Dec 31, 2012 85,000.00
Sep 30, 2012 122,000.00
Jun 30, 2012 164,000.00
Mar 31, 2012 200,000.00
Dec 31, 2011 250,000.00
Sep 30, 2011 306,000.00
Jun 30, 2011 357,000.00
Dec 31, 2010 459,000.00